Table 2.
RS (n=6) | HS (n=6) | HS+Irbesartan (n=6) | HS+Ramipril (n=6) | |
---|---|---|---|---|
JNK1 phosphorylation (% ) | ||||
LV except septum | 105±4 | 108±8 | 111±6 | 105±7 |
Septum | 98±6 | 105±7 | 108±6 | 100±6 |
JNK2 phosphorylation (% ) | ||||
LV except septum | 98±3 | 105±8 | 98±6 | 89±7 |
Septum | 103±7 | 108±5 | 116±9 | 102±8 |
p38 phosphorylation (% ) | ||||
LV except septum | 96±2 | 98±5 | 99±3 | 99±3 |
Septum | 102±5 | 96±5 | 107±4 | 107±3 |
Phosphorylation was calculated as the ratio of phosphorylated form to total form x100.